FN Media Group News Commentary - The healthcare industry is rapidly integrating artificial intelligence (AI)-powered solutions in various verticals to achieve higher operational & clinical outcomes, ...

Brookstone Capital Management lifted its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the ...

Shares of Intuitive Surgical Inc. advanced 7.65% to $580.11 Wednesday, on what proved to be an all-around positive trading ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for the treatment of uncontrolled hypertension.

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Medtronic (MDT – Research Report) today and set a price target of $95.00. The ...